The main market opportunities lie in expanding Whole Genome Sequencing at birth, rapid growth in Direct to Consumer Testing, advancing sequencing technologies, and overcoming industry barriers.

PLEASANTON, Calif., May 12, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG)(OTCQX: RHHBY) today announced the launch of the new KAPA Target Enrichment portfolio, consisting of both exome and custom target ...

Scientists have achieved a significant milestone generating a large collection of exome data, which include genes that code for proteins -- key to understanding health and disease. Mayo Clinic's ...

Genetic mutations in human DNA can prevent proteins that perform important functions in the body from being formed correctly. This can lead to serious disorders that cause disease or even disability.